Full Length Research Paper
References
Bangalore S, Gayathri K, Sanobar P, Franz HM (2007). Fixed-dose combinations improve medication compliance: A Meta-Analysis. Am. J. Med. 120(8):713-719. |
|
Bhosle MJ, Pope ND, Sansgiry SS (2003). Role of the pharmacists in generic substitution practices. American Association of Colleges of Pharmacy Annual Meeting. 104 (Jul): p. IL_0132. |
|
Dimopoulos K, Salukhe TV, Coats AJ, Mayet J, Piepoli M, Francis DP (2004). Meta-analyses of mortality and morbidity effects of an angiotensin receptor blocker in patients with chronic heart failure already receiving an ACE inhibitor (alone or with a beta-blocker). Int. J. Cardiol. 92(2):105-111. |
|
Donovan JL (1995). Patient decision making. Themissing ingredient in compliance research. Int. J. Technol. Assess. Health Care 11(3):443-455. |
|
Dunne S, Shannon B, Hannigan A, Dunne C, Cullen W (2014). Physician and pharmacist perceptions of generic medicines: What they think and how they differ? Health Policy 116:214-223. |
|
Dylst P, Vulto A, Simoens S (2013). Demand-side policies to encourage the use of generic medicines: An overview. Expert Rev. Pharmacoecon. Outcomes Res. 13:59-72. |
|
EGA (European generic medicines association) (2010). Generic medicines: a cornerstone of EU healthcare policy Source: EGA Internal survey. |
|
Figueiras MJ, Marcelino D, Cortes MA (2008). People's views on the level of agreement of generic medicines for different illnesses. Pharm. World Sci. 30(5):590-594. |
|
Mitkova et al. 1025 |
|
Heikkilä R, Mäntyselkä P, Ahonen R (2011). Do people regard cheaper medicines effective? Population survey on public opinion of generic substitution in Finland. Pharmacoepidemiol. Drug Safess. 20(2):185-191. |
|
Kesselheim AS, Misono AS, Lee JL, Stedman MR, Brookhart MA, Choudhry NK, Shrank WH (2008). Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease: A Meta-Analysis. JAMA 300(21):2514-2526. |
|
King DR, Kanavos Ð (2002). Encouraging the Use of Generic Medicines. Implications Trans. Econ. Croat Med. J. 43:462-469. |
|
Limbert C, Lamb R (2002). Doctors' use of clinical guidelines: two application of the theory of planned behaviour. Psychol. Health Med. 7:301-310. |
|
Mott DA, Richard CR (2002). Exploring generic drug use behavior: The role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution. Med. Care 40(8):662-674. |
|
O'Riordan M (2012). One Pill to Cure Them All: Single-Drug Polypharmacy in Cardiovascular Disease. Medscape. Quintal С, Mendes Р(2012). Underuse of generic medicines in Portugal: An empirical study on the perceptions and attitudes of patients and pharmacists. Health Policy 104:61-68. |
|
Sheppard A (2010). Generic Medicines: Essential contributors to the long-term health of society. IMS report. |
|
Simoens S (2013). Sustainable provision of generic medicines in Europe.Brussels: European Generic Medicines Association. |
|
Terrie YC (2010). Monitoring Combination Drug Therapy. Pharmacy Times. |
|
Wald DS, Law M, Morris JK, Bestwick JP, Wald NJ (1999). Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials. Am. J. Med. 122(3):290-300. |
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0